Trupanion, Inc. (NASDAQ:TRUP) SVP Emily Dreyer Sells 3,100 Shares

Trupanion, Inc. (NASDAQ:TRUP) SVP Emily Dreyer sold 3,100 shares of Trupanion stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $54.85, for a total value of $170,035.00. Following the completion of the sale, the senior vice president now owns 24,708 shares of the company’s stock, valued at approximately $1,355,233.80. The trade was a 11.15 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Emily Dreyer also recently made the following trade(s):

• On Monday, November 25th, Emily Dreyer sold 900 shares of Trupanion stock. The stock was sold at an average price of $54.55, for a total transaction of $49,095.00.

Trupanion Price Performance

TRUP stock opened at $53.50 on Thursday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.66 and a current ratio of 1.66. The business has a 50-day simple moving average of $49.50 and a two-hundred day simple moving average of $39.97. The company has a market capitalization of $2.27 billion, a P/E ratio of -167.19 and a beta of 1.69. Trupanion, Inc. has a 52-week low of $19.69 and a 52-week high of $57.90.

Trupanion (NASDAQ:TRUP) last announced its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.09. The company had revenue of $327.50 million for the quarter, compared to analysts’ expectations of $321.79 million. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. Trupanion’s quarterly revenue was up 14.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.10) earnings per share. Research analysts expect that Trupanion, Inc. will post -0.23 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

TRUP has been the topic of several research analyst reports. Stifel Nicolaus increased their target price on shares of Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research note on Monday, September 23rd. Northland Securities increased their price objective on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Evercore ISI raised Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Piper Sandler increased their price target on Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Finally, Bank of America raised their price objective on Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research note on Friday, September 20th. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $44.67.

Institutional Trading of Trupanion

Several institutional investors have recently made changes to their positions in TRUP. Quest Partners LLC bought a new position in shares of Trupanion during the third quarter valued at about $37,000. Wilmington Savings Fund Society FSB purchased a new stake in Trupanion in the 3rd quarter valued at about $54,000. GAMMA Investing LLC lifted its position in shares of Trupanion by 70.4% during the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after buying an additional 596 shares in the last quarter. Headlands Technologies LLC purchased a new position in shares of Trupanion in the 2nd quarter worth approximately $162,000. Finally, Entropy Technologies LP bought a new position in shares of Trupanion in the third quarter valued at approximately $202,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.